Kathleen Joy Propert

faculty photo
Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Member, Graduate Group in Epidemiology and Biostatistics (GGEB),University of Pennsylvania Perelman School of Medicine
Senior Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania Perelman School of Medicine
Member, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine
Director, Biostatistics Core, Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania Perelman School of Medicine
Director of Biostatistics, Integrative Health Sciences Facility Core,Center for Excellence in Environmental Toxicology(CEET), University of Pennsylvania
Department: Biostatistics and Epidemiology

Contact information
Department of Biostatistics and Epidemiology
University of Pennsylvania Perelman School of Medicine
614 Blockley Hall, 423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215-746-8603
Fax: 215-573-4865
Graduate Group Affiliations
Education:
B.S. (Applied Biological Sciences)
Massachusetts Institute of Technology, Cambridge, MA, 1982.
M.S. (Biostatistics)
Harvard School of Public Health, Boston, MA, 1984.
Sc.D. (Biostatistics)
Harvard School of Public Health, Boston, MA, 1990.
Permanent link
 

Description of Itmat Expertise

Dr. Propert directs the Study Design and Biostatistics (SDAB) Core for ITMAT. Her methodological research focus is on optimal study design, particularly for T1 translational research in animal models and early stage clinical trials. Her current clinical areas of focus are traumatic brain injury, lipid metabolism, and pulmonary disease.

Selected Publications

Skarke C, Alamuddin N, Lawson JA, Cen L, Propert KJ, Fitzgerald GA: Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clinical Pharmacology & Therapeutics 91(6): 986-93, June 2012.

Sullivan S, Friess SH, Ralston J, Smith C, Propert KJ, Rapp PE, Margulies SS.: Behavioral deficits and axonal injury persistence following rotational head injury are direction dependent. Journal of Neurotrauma 30(7): 538-45, April 2013.

Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, Nijjar PS, Usman HM, Mehta NN, Shah R, Master SR, Propert KJ, Reilly MP.: Race and gender variation in response to evoked inflammation. Journal of Translational Medicine 11(63), Mar 2013.

Cuchel M, Meagher EA, du Toit Theron H, Blom DJ, Marais AD, Hegele RA, Averna MR, Sirtori CR, Shah PK, Gaudet D, Stefanutti C, Vigna GB, Du Plessis AM, Propert KJ, Sasiela WJ, Bloedon LT, Rader DJ; for the Phase 3 HoFH Lomitapide Study investigators.: Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Lancet 381: 40-6, Jan 2013.

Sullivan S, Friess SH, Ralston J, Smith C, Propert KJ, Rapp PE, Margulies SS: Improved behavior, motor, and cognition assessments in neonatal piglets. Journal of Neurotrauma 30(20): 1770-9, Oct 2013.

Ferguson JF, Mulvey CK, Patel PN, Shah RY, Doveikis J, Zhang W, Tabita-Martinez J, Terembula K, Eiden M, Koulman A, Griffin JL, Mehta NN, Shah R, Propert KJ, Song WL, Reilly MP.: Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Molecular Nutrition & Food Research 58(3): 601-13, Mar 2014.

Verma SM, Okawa J, Propert KJ, Werth VP.: The impact of skin damage due to cutaneous lupus on quality of life. The British Journal of Dermatology 170(2): 315-21, Feb 2014.

Fett N, Haynes K, Propert KJ, Margolis DJ: Five-year malignancy incidence in patients with chronic pruritus: A population-based cohort study aimed at limiting unnecessary screening practices. Journal of the American Academy of Dermatology 70(4): 651-8, 2014 Notes:

Habineza Ndikuyeze G, Gaurnier-Hausser A, Patel R, Baldwin AS, May MJ, Flood P, Krick E, Propert KJ, Mason NJ: A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-Cell like diffuse large B-Cell lymphoma. PLOS One Page: e95404, May 2014.

Saberi P, Propert KJ, Powers M, Emmett E, Green-McKenzie J: Field survey of health perception and complaints of Pennsylvania residents in the Marcellus Shale region. International Journal of Environmental and Public Health 11(6): 6517-27, June 2014.

back to top
Last updated: 01/13/2015
The Trustees of the University of Pennsylvania